Semaglutide pill versus injection: how the two forms of Wegovy compare

Step 1: understand what each form of semaglutide actually does differently

Semaglutide is a GLP-1 receptor agonist made by Novo Nordisk. It slows gastric emptying, reduces appetite and supports weight loss. The mechanism is the same whichever form you take; what changes is how it enters your bloodstream.

The injection is delivered subcutaneously (into the fat layer of the abdomen, thigh or upper arm) once a week. Absorption is predictable and consistent. The tablet uses a co-formulation technology (SNAC) that allows semaglutide to pass through the stomach wall and into the blood when taken on an empty stomach. Because the gut processes tablets differently from injections, a higher oral dose is needed to reach a comparable effect: the maintenance tablet dose is 25 mg, compared with 2.4 mg (or 7.2 mg under the newer pen) for the injection. Neither number is a target you choose, your prescriber titrates you through the schedule. You can read more about how the tablet works on our semaglutide tablets overview.

The injection's once-weekly schedule means you rarely think about it between doses. The tablet is once-daily, first thing, before any food or drink, at least 30 minutes before your coffee or breakfast. That rhythm suits some people perfectly; for others it's a constraint. Worth thinking about before you decide.

Step 2: compare the clinical evidence and eligibility side by side

The injection has the larger evidence base. STEP 1 (published in the New England Journal of Medicine) followed 68 weeks of treatment at 2.4 mg and found an average body-weight reduction of around 15%. The newer 7.2 mg dose, approved by the MHRA in January 2026, produced around 20.7% average loss over 72 weeks in trials. NICE recommends the injection under TA875 for eligible adults on the NHS, though access through NHS specialist services typically involves a wait.

The tablet was approved by the MHRA on 11 June 2026. The OASIS 4 trial (64 weeks, 307 adults with obesity or overweight plus at least one weight-related condition) found an average weight loss of around 13.6% versus around 2.4% on placebo. Among participants who stayed fully adherent, average loss reached about 17%. Most side effects in the trial were gastrointestinal, mild to moderate, and settled over time. The tablet does not yet have a NICE appraisal, so it is not available on the NHS; a private prescription is currently the only route.

Eligibility thresholds differ slightly too. The injection is licensed for adults with BMI 30 or above, or 27–29.9 with at least one weight-related condition. The tablet carries the same broad criteria. Lower BMI thresholds apply for certain ethnic backgrounds under UK guidance.

Step 3: the practical factors that tip the decision one way or the other

Needles are the obvious sticking point for many people. If the thought of a weekly self-injection feels like a hard barrier, the tablet removes it entirely. No sharps, no refrigeration, no worrying whether the hotel mini-bar is cold enough on holiday. You take the tablet the same way you might take a daily vitamin, though the timing rule (empty stomach, plain water, 30 minutes before anything else) does require consistency. If you habitually eat breakfast the moment you get up, that habit needs adjusting.

The injection's once-weekly schedule has its own appeal. You inject on a chosen day, tick it off, and carry on. Some people prefer that rhythm precisely because it's infrequent. If you're someone who finds daily pills easy to forget, a weekly reminder alarm for an injection may actually be the more reliable routine. Our guide on whether Wegovy is a pill or injection explores this question from a different angle if it helps.

There is also the interaction consideration: tirzepatide and the Wegovy injection may reduce absorption of oral contraceptives during the early weeks of treatment, so women on the pill may need an additional method during that period. The same concern applies in principle to the oral semaglutide tablet, so discuss contraception with your prescriber before starting either. And if you have surgery planned (even routine) your clinical team and anaesthetist need to know you are taking a GLP-1 medicine.

If you order the injection and dispatch happens on a Friday before a bank holiday weekend, delivery timing shifts. Our prescribers flag this during review, which is one reason same-day clinical assessment matters rather than automated processing.

Neither form is right for everyone, and neither is available without a prescription. If you want a closer look at how the two routes compare before committing, our page on whether semaglutide pills or injections suit you better is worth reading alongside our more detailed breakdown of semaglutide tablets versus injection. The oral versus injection comparison on our site covers some of the same ground with different framing; the Wegovy tablet cost page explains what private pricing typically looks like. For the broader picture of all weight-loss treatment options, the weight-loss overview is a sensible next step.

Which form suits you is a clinical decision our prescribers make with you, based on your health history, your routine, and what you actually want from treatment. Our FAQs cover many of the questions that come up before that conversation. If you're ready to start, begin your free consultation here and a GPhC-registered prescriber will review your answers the same day.